Karen Lee

Title: The Innovations of Karen Lee

Introduction

Karen Lee is an accomplished inventor based in Bridgewater, NJ (US). She has made significant contributions to the field of biotechnology, particularly in the development of recombinant glycoproteins. Her work has implications for pharmaceutical applications and treatment methodologies.

Latest Patents

Karen Lee holds a patent for "Recombinant glycoproteins and uses thereof." This patent includes recombinant human α-galactosidase-A proteins with an improved glycosylation profile. The patent also covers pharmaceutical compositions and kits that incorporate these proteins. Additionally, it outlines methods for generating mammalian cells useful for the recombinant expression of glycoproteins, as well as methods for producing these proteins and administering them for treatment.

Career Highlights

Karen Lee is associated with Genzyme Corporation, a leading biotechnology company. Her role at Genzyme has allowed her to focus on innovative solutions in the field of glycoprotein research. She has been instrumental in advancing the understanding and application of recombinant proteins in medicine.

Collaborations

Karen has collaborated with notable colleagues, including Christopher Hwang and Christine T DeMaria. These collaborations have fostered a productive environment for research and development in their respective fields.

Conclusion

Karen Lee's contributions to biotechnology through her patent on recombinant glycoproteins exemplify her innovative spirit and dedication to advancing medical science. Her work continues to impact the pharmaceutical industry positively.